SEARCH

SEARCH BY CITATION

References

  • 1
    Strachan DP. Hay fever, hygiene and household size. BMJ 1989: 299: 125960.
  • 2
    Strachan DP. Epidemiology of hay lever: towards a community diagnosis. Clin Exp Allergy 1995:25:296303.
  • 3
    Romagnani S. Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 1992; 98: 27985.
  • 4
    Strachan DP. Is allergic disease programmed in early life? Clin Exp Allergy 1994; 24: 6035.
  • 5
    Shaheen SO, Aaby P, Hall AJ, et al. Measles and atopy in Guinea-Bissau. Lancet 1996; 347: 17926.
  • 6
    Matricardi PM, Rosmini F, Ferrigno L, et al. Cross-sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ 1997; 314: 9991003.
  • 7
    Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997; 275: 779.
  • 8
    Serafini U. Do infections protect against asthma and atopy? Allergy 1997; 52: 9557.
  • 9
    Martinez FD, Stern DA, Wright AL, Taussig LM, Halonen M, and Group of Health Medical Associates. Association of non-wheezing lower respiratory tract illnesses in early life with persistently diminished serum IgE levels. Thorax 1995; 50: 106772.
  • 10
    Wilson AF, Novey HS, Berke RA, Surprenant EL. Deposition of inhaled pollen and pollen extract in human airways. N Engl J Med 1973; 288: 10569.
  • 11
    Auci DL, Chice SM, Heusser C, Athanassiades TJ, Durkin HG. Gut-associated lymphoid tissue as sites of first appearance of IgE-bearing B lymphocytes and hapten-specific IgE antibody-forming cells in mice immunized with benzylpenicilloyl-KLH by various routes. J Immunol 1992; 149: 22418.
  • 12
    Wallaert B, Desrcumaux P, Copin MC, et al. Immuno-reactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma. J Exp Med 1995: 182: 18971904.
  • 13
    Holt PG. Infections and the development of atopy. Toxicol Lett 1996: 86: 20510.
  • 14
    Maggi E, Parronchi P, Manetti R, et al. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Till and Th2 clones. J Immunol 1992; 148: 21427.
  • 15
    Bonini S, Magrini L, Rotiroti G, Ronchetti MP, Onorati P. Genetic and environmental factors in the changing incidence of allergy. Allergy 1994; 49 Suppl 18: 614.
  • 16
    Brown M, Halonen MJ, Martinez F. Culling the cord: is birth already too late for primary prevention of allergy? Clin Exp Allergy 1997; 27: 46.
  • 17
    Kalyoncu AF, Stålenheim G. Serum IgE levels and allergic spectra in immigrants to Sweden. Allergy 1992; 47: 27780.
  • 18
    Jarvis D, Chinn S, Loczynska C, Burney P. The association of family size with atopy and atopic disease. Clin Exp Allergy 1997; 27: 2405.
  • 19
    Cookson WOCM, Moffatt MF. Asthma: an epidemic in the absence of infection Science 1997: 275: 412.
  • 20
    Hopkin JM. Atopic disease and immunologic response Science 1997: 276: 1719.
  • 21
    Holt PG. A potential vaccine strategy for asthma and allied atopic diseases during early childhood. Lancet 1994; 344: 4568.
  • 22
    Shaheen S. Discovering the causes of atopy. BMJ 1997; 314: 9878.
  • 23
    Krause RM. Epidemiology of allergic diseases: a neglected opportunity. J Allergy Clin Immunol 1986; 78: 9534.